Weight gain may increase risk of breast cancer in postmenopausal womenJuly 12, 2006Weight gain, particularly after menopause, is associated with an increased risk of breast cancer in women, according to an article in the July 12 issue of JAMA. Background information in the article indicates that weight loss after menopause lowers circulating estrogen hormones in women, and because estrogen is directly related to breast cancer, weight loss is thought to decrease risk of the disease. Studies show that weight gain since early adulthood is associated with increased breast cancer risk in postmenopausal women, particularly those not taking postmenopausal hormones. However, weight changes in middle-aged to older women (50 years and older) has been studied less extensively. A. Heather Eliassen, Sc.D., of Brigham and Women's Hospital and Harvard Medical School, Boston, and colleagues analyzed data within the Nurses' Health Study to determine the association between weight change and the risk of breast cancer among postmenopausal women. The researchers assessed weight change for two different periods—since 18 years of age and since menopause. A total of 87,143 postmenopausal women (ages 30 to 55 years) were followed up for up to 26 years to analyze weight change since age 18. Weight change since menopause was assessed among 49,514 women (followed up for up to 24 years).
Women who gained about 55 pounds or more since age 18 were at a 45 percent increased risk of breast cancer, compared with those who maintained their weight, with a stronger association among women who have never taken postmenopausal hormones. Women who gained about 22 pounds or more since menopause were at an 18 percent increased risk of breast cancer. Those who lost about 22 pounds or more since menopause (and kept the weight off) and had never used postmenopausal hormones were at a 57 percent lower risk of breast cancer than those who simply maintained their weight. The researchers concluded that 15 percent of the study's breast cancer cases may be attributable to weight gain of 4.4 pounds or more since age 18 and 4.4 percent of the cases may be attributable to weight gain of 4.4 pounds or more since menopause. "These data suggest that weight gain during adult life, specifically since menopause, increases the risk of breast cancer among postmenopausal women, whereas weight loss after menopause is associated with a decreased risk of breast cancer," the authors write. \\\ JAMA and Archives Journals | |||||||||||||||||||||
|
Related Breast Cancer News Articles CSHL scientists identify new drug target against virulent type of breast cancer Tumor cells in a particular subset of breast cancer patients churn out too much of a protein called ErbB2 -- also often called HER2 -- which drives the cells to proliferate unchecked. Patients unlucky enough to be in this group -- about one in four -- have poorer prognoses and clinical outcomes than those who don't. Dense tissue promotes aggressive cancers New research may explain why breast cancer tends to be more aggressive in women with denser breast tissue. Breast cancer cells grown in dense, rigid surroundings step up their invasive activities, Vanderbilt-Ingram Cancer Center investigators report in the Sept. 9 issue of Current Biology. Women exposed to negative life events at greater risk of breast cancer: BGU study Happiness and optimism may play a role against breast cancer while adverse life events can increase the risk of developing the disease. Hormone replacement therapy improves sleep, sexuality and joint pain in older women One of the world's longest and largest trials of hormone replacement therapy (HRT) has found that post-menopausal women on HRT gain significant improvements in quality of life. Positive thinking may protect against breast cancer Feelings of happiness and optimism play a positive role against breast cancer. Research published today in the open access journal BMC Cancer suggests that while staying positive has a protective role, adverse life events such as the loss of a parent or close relative, divorce or the loss of a spouse can increase a woman's risk of developing the disease. Anti-tumor effects are enhanced by inhibiting 2 pathways rather than 1 Two independent research groups have found that simultaneous inhibition of two signaling pathways resulted in substantially enhanced antitumor effects in mouse models of prostate and breast cancer. In an accompany commentary, Steven Grant, at Virginia Commonwealth University Health Science Center, Richmond, discusses the clinical importance of these studies and highlights some of the questions that still need to be answered. Why a common treatment for prostate cancer ultimately fails Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the Proceedings of the National Academy of Sciences. Duke chemists synthesize promising anti-cancer product Duke University chemists have patented an efficient technique for synthesizing a marine algae extract in sufficient quantities to now test its ability to inhibit the growth of cancerous cells while leaving normal cells unaffected. Slipping through cell walls, nanotubes deliver high-potency punch to cancer tumors in mice The problem with using a shotgun to kill a housefly is that even if you get the pest, you'll likely do a lot of damage to your home in the process. Hence the value of the more surgical flyswatter. Targeted radiation therapy can control limited cancer spread Precisely targeted radiation therapy can eradicate all evidence of disease in selected patients with cancer that has spread to only a few sites, suggests the first published report from an ongoing clinical trial. More Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||